cryptocurrency founded- Top searches

Reserve Bank of Australia President Brock: The change in wording of the central bank's monetary policy committee is intentional. Reserve Bank of Australia President Brock: The change in wording of the statement is intentional. The Committee noted that the data had weakened. Have more confidence in inflation. The Committee believes that the economic situation is basically in line with expectations. No need for two or more quarterly inflation data to change. Will pay attention to all data including employment.Minister of Malaysia: ZTE will invest 200 million ringgit in Malaysia.Reserve Bank of Australia President Brock: I'm not sure if we will cut interest rates in February. It will be necessary to pay attention to the slowdown in data, wages and demand. If the inflation rate does not drop, then we will face another problem.

Australian Treasury Secretary chalmers: The new A $2 billion expenditure on natural disaster preparedness will affect the mid-year economic and financial outlook.Japan Meteorological Agency: There is a 70% chance that La Niñ a will not occur before the arrival of spring. The Japan Meteorological Agency said that there are no signs of El Niñ o and La Niñ a at present, but the characteristics of La Niñ a are emerging. There is a 70% chance that La Nina will not occur before the spring comes.Gaode Infrared sued six former employees and their new owners for infringing on business secrets. The other company: Gaode Infrared announced that there were "false records and false statements". On the evening of December 5, Gaode Infrared announced that the company filed a civil lawsuit against Zhejiang Juexin Microelectronics Co., Ltd. (hereinafter referred to as Juexin Company), Mao Jianhong and six former employees for infringing on the company's business secrets, asking the defendant to pay 200 million yuan in economic losses and other things. On December 6th and 9th, Juexin Company issued statements on the announcement of Gaode Infrared on WeChat WeChat official account "Juexin Microelectronics", claiming that there were "false records, false statements, misleading statements or major omissions" in the above announcement of Gaode Infrared. (per warp net)

Sichuan Luqiao established a new building materials company, and the enterprise search APP showed that recently, Sichuan Jiaojian Building Materials Co., Ltd. was established, with Qu Hong as the legal representative and a registered capital of 5 million yuan. Its business scope includes: sales of building materials; Non-metallic minerals and products sales; Manufacturing of nonmetallic mineral products; Metal ore sales, etc. Enterprise survey shows that the company is indirectly wholly-owned by Sichuan Luqiao.The researcher of Everbright Bank commented on China's import and export data in November: the export growth rate is stronger than seasonality, and foreign trade exports are expected to grow steadily in the next few months. Zhou Maohua, a macro researcher in the financial market department of Everbright Bank, told Wall Street that the export growth rate in November was stronger than seasonality, the import decline exceeded expectations (weaker than seasonality), the trade surplus expanded, and foreign trade contributed more to the economy in the fourth quarter. Due to the resilience of overseas demand, overseas foreign trade importers rushed to avoid tariffs and hoarded goods in advance, and the effects of policies such as stabilizing foreign trade appeared, driving export growth to exceed expectations; The decline in imports in November exceeded expectations, mainly due to the weak recovery of domestic demand, the cautious decision of enterprises to expand and increase import inventory, and the low prices of international energy and other commodities that depressed the overall import cost.Shisi Pharmaceutical Group: Dilalos dispersible tablets (125mg) have obtained the approval of pharmaceutical production registration. Shisi Pharmaceutical Group announced on the Hong Kong Stock Exchange on December 10th that it has obtained the approval of pharmaceutical production registration of Dilalos dispersible tablets (125mg) in National Medical Products Administration, China, which belongs to the fourth category of chemicals and is deemed to have passed the consistency evaluation. Deslorax dispersible tablets are mainly used to treat chronic iron overload caused by frequent blood transfusion in patients with β -thalassemia over two years old, and chronic iron overload in patients with transfusion-independent thalassemia syndrome over 10 years old.